This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Polyhydramnios

Authoring team

Polyhydramnios is a common obstetric complication.

Polyhydramnios is a condition where there is too much amniotic fluid. The normal range is 400-1500 ml with an average of 800 ml.

On clinical examination, only volumes in excess of 2000 ml are reliably detected.

Empirically, polyhydramnios is defined as the presence of amniotic fluid pool depth of greater than 10 cm on an ultrasound scan (the normal is from 2 to 10 cm).

Aetiology of polyhydramnios is varied:

  • aneuploidy is present in 10% of fetuses with sonographic anomalies and in 1% when the ultrasound examination is considered to be normal
  • in persistent polyhydramnios, the prevalence of aneuploidy is increased (10-20%) compared with polyhydramnios with spontaneous resolution
  • other major causes of polyhydramnios include maternal diabetes, isoimmunisation disease, congenital abnormalities and multiple gestations

In a large number of pregnancies, the polyhydramnios remain unexplained despite extensive prenatal assessment (2)

Unexplained polyhydramnios has been associated with significantly higher rates of malpresentation, macrosomia, primary caesarean delivery and an increased rate of perinatal mortality (2).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.